SPYM vs VFMO: 22% overlap
State Street SPDR Portfolio S&P 500 ETF and Vanguard U.S. Momentum Factor ETF share 21.8% of their portfolios by weight — computed as Σ min(wA, wB) over every holding both funds own.
Different holding dates. These holdings were published about 4 months apart — VFMO as of 2026-03-31, the rest through 2026-07-27. Each fund is compared using its most recent file, so any trading in between shows up as a difference.
You would hold two tickers and get the diversification of 1.8. Two funds that shared nothing would score 2.0; two identical funds score 1.0.
Top shared holdings
SPYM and VFMO hold 131 of the same securities. The ten contributing most to the overlap figure:
| Holding | in SPYM | in VFMO | Δ |
|---|---|---|---|
| JNJ | 1.0% | 1.0% | 0.0% |
| AMD | 1.3% | 1.0% | 0.3% |
| GOOGL | 3.0% | 0.9% | 2.1% |
| MU | 1.6% | 0.8% | 0.8% |
| INTC | 0.7% | 0.8% | 0.1% |
| AMAT | 0.6% | 0.9% | 0.2% |
| CAT | 0.6% | 0.8% | 0.2% |
| AVGO | 2.8% | 0.6% | 2.2% |
| GE | 0.6% | 0.6% | 0.0% |
| GOOG | 2.4% | 0.6% | 1.8% |
Where SPYM and VFMO differ
Sector weights as a share of each fund, ordered by the size of the gap rather than the size of the sector — two funds that overlap heavily still usually diverge somewhere.
| Sector | SPYM | VFMO | Δ |
|---|---|---|---|
| Information Technology | 36.8% | 17.0% | +19.8pp |
| Industrials | 8.9% | 24.4% | −15.5pp |
| Health Care | 9.2% | 22.3% | −13.1pp |
| Financials | 12.6% | 6.3% | +6.3pp |
| Communication Services | 9.5% | 3.4% | +6.1pp |
| Energy | 3.3% | 7.7% | −4.4pp |
| Materials | 1.9% | 6.2% | −4.3pp |
| Consumer Staples | 4.7% | 2.4% | +2.3pp |
Δ is SPYM minus VFMO, in percentage points. Sector data is not published by every issuer, so “Unclassified” is a real category rather than a gap in the table.
What each fund holds alone
64.2% of SPYM by weight, held in no part of VFMO.
56.5% of VFMO by weight, held in no part of SPYM.
A large count with a small weight is the usual shape: the positions one fund adds are typically its smallest ones.
Concentration and cost
| SPYM | VFMO | |
|---|---|---|
| Top 10 holdings | 36.7% | 10.2% |
| Positions held | 507 | 672 |
| Cost per $10,000 held, per year | $2 | $13 |
Cost is the expense ratio applied to $10,000; it excludes any brokerage commission, bid-ask spread or tax consequence. Figures are facts about the funds, not a suggestion about which to hold.
Frequently asked
How much do SPYM and VFMO overlap?
SPYM and VFMO overlap 21.8% by portfolio weight — moderate overlap. They share 131 holdings. The figure comes from current issuer holdings files (SPYM as of 2026-07-27, VFMO as of 2026-03-31).
How is the overlap between SPYM and VFMO calculated?
As the sum of the smaller weight in each fund, over every holding both funds own: Σ min(wA, wB). If SPYM holds a stock at 6% and VFMO holds the same stock at 4%, 4% counts as shared. The result is bounded between 0% and 100%, and it is computed after looking through any fund-of-funds to the underlying holdings.
Is it redundant to hold both SPYM and VFMO?
That depends on your goals — we state facts, not advice. At 21.8% overlap, each fund still contributes meaningfully distinct exposure.
What does SPYM own that VFMO doesn't?
SPYM holds 507 positions and VFMO holds 672; 375 of SPYM's positions don't appear in VFMO at all, and they are 64.2% of SPYM by weight.
You probably hold more than two funds
This page compares SPYM and VFMO. Paste your whole portfolio — brokerage, 401(k), IRA — and see the overlap across every fund at once, plus what you actually own underneath them and your own Effective Funds number. Free, no account, nothing stored.
X-ray my portfolio — free →Watch SPYM vs VFMO
We re-read both funds’ published holdings every weeknight. Leave an address and we'll tell you when what's inside actually changes.
Not sending yet — email alerts are built but switched off, and you'll be among the first when they turn on. No spam, one-click unsubscribe.
Related comparisons
Sources: issuer holdings files, SPYM as of 2026-07-27, VFMO as of 2026-03-31. Weights are fractions of each fund. Diagnostics, not advice.